Pricing Log in Create free account

Evommune Inc. (EVMN) vs InflaRx N.V. (IFRX)

Evommune Inc. and InflaRx N.V. are both Biotechnology companies. Evommune Inc. and InflaRx N.V. are of similar size ($215.2M and $212.2M). Across the 11 metrics below, InflaRx N.V. leads on 7 and Evommune Inc. on 4.

Valuation

Metric EVMN IFRX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 5,075.70 9.71
P/B 0.67 0.91 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.13 0.71 0.64
EV/Sales n/m (1,061.22) 9.21
Earnings yield (213.35%) (43.94%) (33.15%)
Free cash flow yield (39.96%) (17.60%) (25.50%)

Profitability

Metric EVMN IFRX Biotechnology median
Gross margin — (26,762.42%) 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (141.99%) (38.71%) (56.36%)
Return on assets (62.71%) (32.75%) (48.04%)
Return on invested capital (82.46%) 0.00% 0.00%

Growth

Metric EVMN IFRX Biotechnology median
Revenue growth (TTM) — (83.39%) 6.02%
EPS growth (last fiscal year) 75.23% 9.41% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EVMN IFRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.68 8.22 4.72
Net debt to EBITDA 1.87 0.97 0.96

Dividend

Metric EVMN IFRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EVMN IFRX Biotechnology median
Market cap 215.22m 212.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack